Introduction
Recently, some guidelines recommend conducting colorectal cancer (CRC) screening at ages younger than 50 years. However, there are few data on the preventive effect of colonoscopy at ages 40-49 years at the population level.
Aims & Methods
In this study, the risk of CRC according to the presence or absence of CSP in their 40s was evaluated in a retrospective cohort design using a nationwide database. Using the Korean National Health Insurance System data between 2004 and 2006, we constructed 1:5 colonoscopy cohort (CsC) and non-colonoscopy cohort (NCsC) at ages 40-49 years and followed through 2014. A total of 2,940,792 subjects were enrolled and CRC risk was evaluated after propensity score matching between CsC and NCsC based on age, sex, smoking, metabolic syndrome (MetS) and potentially relevant variables related CRC risk.
Results
Among 490,132 CsC subjects and 2,450,660 NCsC subjects at baseline periods in 40-49 ages, 689 (0.14%) and 9,440 (0.39%) cases of CRC were found during 10 years follow up period, respectively. According to age group, cumulative CRC incidences in early 40’s (40-44) were 0.10% in CsC and 0.25% in NCsC respectively. For late 40’s (45-49), those were 0.17% in CsC group and 0.49% in NCsC group, respectively. Compared with NCsC, the adjusted hazard ratios (aHRs) for CRC development in CsC group were 0.42 (men, 95% CI: 0.35-0.50) and 0.37 (women, 95% CI: 0.30-0.47) in early 40’s and 0.33 (men, 95% CI: 0.29-0.37) and 0.39 (women, 95% CI: 0.33-0.45) in late 40’s.
Conclusion
Overall, colonoscopy in their 40s significantly lowered the risk of colorectal cancer development by 58-67%. This cancer prevention effect of colonoscopy was different according to age and gender, and it was most effective in men in their late 40s, suggesting the rationales for optimization of age and gender to start colonoscopy.
Disclosure
Korea Health Technology R&D Project through the Korea Health Industry Development Institute, National Research Foundation of Korea grant and the National R&D Program for Cancer Control through the National Cancer Center funded by the Korea Ministry of Health & Welfare, Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education.